Literature DB >> 26674546

Histopathological Spectrum of Tumor and 
Tumor-like Lesions of the Paratestis in a 
Tertiary Care Hospital.

Siddhi G S Khandeparkar1, R G W Pinto2.   

Abstract

OBJECTIVES: Tumors and tumor-like lesions (TLL) of the paratesticular region are rare. Very few studies depicting the spectrum of lesions of this location are available in the literature. Malignant neoplasms arising in the paratesticular region represent only 7.0% of malignant tumors presenting as a scrotal mass. TLL and benign tumors are of great interest, because of their topography they can simulate a neoplasm in the paratesticular structures. We sought to study the incidence, nature, pattern, clinical, immune, and histopathological characteristics of tumors and TLL of the paratestis.
METHODS: In this six-year study, records of the cases were reviewed and the histopathology slides were reassessed. Blocks were retrieved and stained immunohistochemically for relevant markers.
RESULTS: A total of 47 cases of tumor and TLL of the paratestis were diagnosed over a six-year period. The patients ranged from one to 76 years old and most presented with a scrotal mass. Of these, seven (14.9%) were benign. Lipoma was the most common benign tumor. One case each of adenomatoid tumor, scrotal hemangioma, solitary fibrous tumor, and papillary cyst adenoma were reported. The TLL (70.2%) comprised of 17 cases of epididymal cyst, seven cases of tuberculous epididymitis, four cases of filarial epididymitis, two cases each of non-specific granulomatous epididymitis and fibromatous periorchitis, and one case of mesothelial cyst. Seven malignant tumors (14.9%) were diagnosed all of which were sarcomas. All seven were primary to the paratesticular region. The most common malignant tumor was embryonal rhabdomyosarcoma. One case each of malignant mesothelioma, malignant fibrous histiocytoma, atypical lipomatous tumor/well-differentiated liposarcoma, and myxoid liposarcoma were identified.
CONCLUSION: Neoplasms of the paratesticular region affect patients of all ages, with potentially life-threatening sequelae. Awareness of the entire spectrum and meticulous histopathological examination and immunohistochemical studies are of prime importance in the diagnosis of the various lesions as these influence the mode of therapy and subsequent prognosis of the patient.

Entities:  

Keywords:  Benign Neoplasms; Immunohistochemistry; Paratesticular region; Rhabdomyosarcoma, Embryonal; Tumors

Year:  2015        PMID: 26674546      PMCID: PMC4678445          DOI: 10.5001/omj.2015.90

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  20 in total

1.  Rare case of paratesticular solitary fibrous tumour (lipomatous hemangiopericytoma).

Authors:  Yagil Barazani; Basir Tareen
Journal:  Can Urol Assoc J       Date:  2012-06       Impact factor: 1.862

Review 2.  Testicular and paratesticular neoplasms in prepubertal males.

Authors:  Piyush K Agarwal; Jeffrey S Palmer
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

3.  [Non-specific granulomatous epididymitis].

Authors:  M Medina Pérez; J A Valero Puerta; M J Martínez Igarzabal
Journal:  Arch Esp Urol       Date:  2000-05       Impact factor: 0.436

4.  Management of epididymal cysts in childhood.

Authors:  Volkan Erikci; Münevver Hoşgör; Nail Aksoy; Özkan Okur; Melih Yildiz; Ahmet Dursun; Yusuf Demircan; Yilmazcan Örnek; İncinur Genişol
Journal:  J Pediatr Surg       Date:  2013-10       Impact factor: 2.545

5.  Management of spermatic cord tumors: a rare urologic malignancy.

Authors:  Dayron Rodríguez; Aria F Olumi
Journal:  Ther Adv Urol       Date:  2012-12

Review 6.  Multimodality imaging of paratesticular neoplasms and their rare mimics.

Authors:  Syed Ali Akbar; Tawfeeq Amjadali Sayyed; Syed Zafar Hasan Jafri; Farnaz Hasteh; James Simeon Adams Neill
Journal:  Radiographics       Date:  2003 Nov-Dec       Impact factor: 5.333

7.  Paratesticular sarcomas: A report of seven cases.

Authors:  Yaşar Unlü; Gülben Erdem Huq; Gülzade Ozyalvaçli; Mehmet Zengin; Sevim Baykal Koca; Uğur Yücetas; Erol Rüştü Bozkurt; Kemal Behzatoğlu
Journal:  Oncol Lett       Date:  2014-10-23       Impact factor: 2.967

8.  Malignant mesothelioma of the tunica vaginalis: presenting with intermittent scrotal pain and hydrocele.

Authors:  Tarık Esen; Omer Acar; Kamil Peker; Kemal Sarman; Ahmet Musaoglu; Ahmet Tefekli
Journal:  Case Rep Med       Date:  2012-07-18

9.  Paratesticular liposarcoma: a case report and review of the literature.

Authors:  Haider Alyousef; Elsawi M Osman; Mohamed A Gomha
Journal:  Case Rep Urol       Date:  2013-02-28

10.  Adenomatoid tumor of epididymidis: A case report.

Authors:  Stylianos Kontos; Ioannis Fokitis; Antigoni Karakosta; Georgios Koritsiadis; Konstantinos Mitsios; Stamatios Koutsikos; Sotirios Koritsiadis
Journal:  Cases J       Date:  2008-10-02
View more
  5 in total

1.  Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed.

Authors:  Sofia Santos-Lopes; João Lobo; Rui Henrique; Jorge Oliveira
Journal:  Urol Ann       Date:  2017 Jan-Mar

2.  The Dilemma in the Diagnosis of Paratesticular Lesions.

Authors:  Sajika P Dighe; Raju K Shinde; Sangita J Shinde; Pratikshit S Raghuwanshi
Journal:  Cureus       Date:  2022-03-02

3.  Painless Left Scrotal Mass: A Rare Case of Paratesticular Angiofibroma.

Authors:  Mustafa T Owaidah; Mohamad Bakir; Maher Moazin; Naif Aldaham; Saad R Alqasem; Abdullah Alfakri; Sami Almustanyir
Journal:  Cureus       Date:  2022-04-19

4.  TESTICULAR ADNEXAL MESENCHYMAL TUMOURS IN IBADAN, NIGERIA: HISTOPATHOLOGIC SPECTRUM AND CHARACTERISTICS.

Authors:  G O Ogun; A O Takure; U S Ezenkwa; I N Chibuzor
Journal:  J West Afr Coll Surg       Date:  2018 Apr-Jun

5.  Histopathological Pattern of Testicular Lesions in Kano, Northwestern Nigeria.

Authors:  Abubakar Abdulkadir; Haruna Muhammad Sanusi; Sule Alfa Alhaji
Journal:  Niger J Surg       Date:  2019 Jul-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.